Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers’ Compensation for Employees with Multiple Sclerosis
Background: Employers offer a variety of absence benefits. It is unknown how benefit design impacts the use of the benefits, the length of...
The Importance of Specialty Pharmacy Services in Multiple Sclerosis Patient Care
Background: Johns Hopkins Specialty Pharmacy provides clinical services for eligible multiple sclerosis (MS) patients on oral and...
Differences in Expected Number of Clinical Management Events before and during Treatment with Sphingosine-1-Phosphate Receptor Modulators for Multiple Sclerosis
Background: Sphingosine-1-phosphate receptor modulators (S1Ps), a class of oral disease-modifying therapies (DMTs) for multiple sclerosis...
Telehealth Utilization and Clinical Outcomes in Four MS Centers during the COVID Pandemic: Real-World Evidence from the MS-Cqi Improvement Research Collaborative.
Background: MS-CQI is the first multi-center improvement research collaborative for MS care. MS-CQI was a three-year study (2018-2020) to...
Improving Communication about Multiple Sclerosis: The MS-Support Decision Aid
Background: Good communication between patients and their health care provider (HCP) is essential for shared decision making (SDM). We...
A Coach Supported Standardized Approach for Quality Improvement (QI) in the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative.
Background: MS-CQI is the first multicenter improvement research collaborative for MS. MS-CQI was a three-year study (2018-2020) of...
Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes
Background: There are more than 20 disease modifying therapies (DMTs) approved for treatment of Multiple Sclerosis. Previous studies in the...
The Relationship between Illness Intrusiveness and Walking in Persons with Multiple Sclerosis
Background: Walking impairment is one of the hallmark symptoms of persons with multiple sclerosis (PwMS) and affects activities of daily...
The Can Do Multiple Sclerosis Outcomes Study: Study Design to Evaluate Program Outcomes
Background: Assessment of self-efficacy has been a focus of Can Do MS programs given prior research showing associations between higher...